InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma

Yufang Ma, Nan Tang, Reid C. Thompson, Bret C. Mobley, Steven W. Clark, Jann N. Sarkaria, Jialiang Wang

Clinical Cancer Research · 2015 · 79 citations · 39 references

DOIFull text

Open access

Abstract

Our results suggest that activation of the InsR/IGF1R pathway confers resistance to EGFR inhibitors in EGFR-dependent glioblastoma through AKT regulation. Concurrent blockade of these two pathways holds promise to treat EGFR-dependent glioblastoma.

References

39